Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 6/20 | 0.45 |
| ▸ | TBXA2R | P21731 | 6/20 | 0.45 |
| ▸ | ACSS2 | Q9NR19 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | CFTR | P13569 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31159736 | 0.84 | GLP1R (0.45) | DRD2TBXA2RACSS2KDM4E | |
| SCHEMBL20266537 | 0.84 | GLP1R (0.45) | DRD2TBXA2RACSS2KDM4E | |
| Hydrochloric Acid SCHEMBL30269640 | 0.84 | GLP1R (0.44) | DRD2TBXA2RACSS2KDM4E | |
| Hydrochloric Acid SCHEMBL28910361 | 0.84 | GLP1R (0.44) | DRD2TBXA2RACSS2KDM4E | |
| SCHEMBL30269261 | 0.81 | ALOX5AP (0.44) | DRD2TBXA2RACSS2KDM4E | |
| SCHEMBL29559474 | 0.80 | TLR7 (0.48) | DRD2TBXA2RACSS2KDM4EHTT | |
| SCHEMBL20280108 | 0.80 | TLR7 (0.48) | DRD2TBXA2RACSS2KDM4EHTT | |
| SCHEMBL24265281 | 0.80 | ACSS2 (0.49) | DRD2TBXA2RACSS2KDM4ECFTR | |
| Hydrochloric Acid SCHEMBL20266404 | 0.79 | TLR7 (0.47) | DRD2TBXA2RACSS2KDM4EHTT | |
| SCHEMBL29040863 | 0.79 | DNMT1 (0.46) | DRD2TBXA2RACSS2KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210047298-A1 | GLP-1 RECEPTOR AGONISTS AND USES THEREOF | PFIZER INC. (US) | 2021-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210047298-A1 | GLP-1 RECEPTOR AGONISTS AND USES THEREOF | GLP1R, GIPR, GPR119 | DRD2 3291/4885TBXA2R 130/4885ACSS2 1602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.